Dr. Subrata Das

Dr. Subrata Das

orcid

Research Focus & Metrics

Academic Career Length

4Years (2023-Present)

(Calculated once Scilit publication data is synced: current year − year of first publication + 1)

Representative Publications

View All Publications
12 May 2023 in Plants
Verified
Journal Article
Open access
PDF file
Rosa TundisRosa Tundis
Rosa Tundis
Jayanta Kumar PatraJayanta Kumar Patra
Jayanta Kumar Patra
MBMarco Bonesi
Marco Bonesi
DDDr. Subrata Das
Dr. Subrata Das
Rajat NathRajat Nath
Rajat Nath
Monica Rosa LoizzoMonica Rosa Loizzo
Monica Rosa Loizzo
In spite of the progress in treatment strategies, cancer remains a major cause of death worldwide. Therefore, the main challenge should be the early diagnosis of cancer and the design of an optimal therapeutic strategy to increase the patient’s life expectancy as well as the continuation of the search for increasingly active and selective molecules for the treatment of different forms of cancer. In the recent decades, research in the field of natural compounds has increasingly shifted towards advanced and molecular level understandings, thus leading to the development of potent anti-cancer agents. Among them is the diterpene lactone andrographolide, isolated from Andrographis paniculata (Burm.f.) Wall. ex Nees that showed shows a plethora of biological activities, including not only anti-cancer activity, but also anti-inflammatory, anti-viral, anti-bacterial, neuroprotective, hepatoprotective, hypoglycemic, and immunomodulatory properties. Andrographolide has been shown to act as an anti-tumor drug by affecting specific molecular targets that play a part in the development and progression of several cancer types including breast, lung, colon, renal, and cervical cancer, as well as leukemia and hepatocarcinoma. This review comprehensively and systematically summarized the current research on the potential anti-cancer properties of andrographolide highlighting its mechanisms of action, pharmacokinetics, and potential side effects and discussing the future perspectives, challenges, and limitations of use.

11 December 2024
Verified
Book Chapter
Closed access
PDF file
DDDr. Subrata Das
Dr. Subrata Das
ATAnupam Das Talukdar
Anupam Das Talukdar
DDDipika Das
Dipika Das
DNDeepa Nath
Deepa Nath